Sources | Names Used |
---|---|
CCLE, GDSC1000 | PD-0325901 |
gCSI | pd0325901 |
PharmacoGx | PD-0325901 |
Database | Identifier |
---|---|
Smiles: | C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O |
Inchikey: | SUDAHWBOROXANE-SECBINFHSA-N |
Pubchem: | 9826528 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SPRY2 | CCLE | pan-cancer | AAC | 0.43 | 9e-21 |
mRNA | SLC35D2 | CCLE | pan-cancer | AAC | 0.47 | 2e-16 |
mRNA | LYZ | CCLE | pan-cancer | AAC | 0.35 | 6e-15 |
mRNA | ETV4 | CCLE | pan-cancer | AAC | 0.36 | 6e-15 |
mRNA | DUSP6 | CCLE | pan-cancer | AAC | 0.33 | 2e-14 |
mRNA | NPAS2 | CCLE | pan-cancer | AAC | 0.32 | 1e-12 |
mRNA | FCER1G | CCLE | pan-cancer | AAC | 0.3 | 4e-12 |
mRNA | BACH2 | CCLE | pan-cancer | AAC | -0.32 | 4e-12 |
mRNA | SPRY4 | CCLE | pan-cancer | AAC | 0.33 | 5e-12 |
mRNA | HSD17B6 | CCLE | pan-cancer | AAC | -0.31 | 7e-12 |